Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer

被引:0
|
作者
Aikawa, H [1 ]
Takahashi, H [1 ]
Fujimura, S [1 ]
Sato, M [1 ]
Endo, C [1 ]
Sakurada, A [1 ]
Kondo, T [1 ]
Tanita, T [1 ]
Matsumura, Y [1 ]
Ono, S [1 ]
Saito, Y [1 ]
Sagawa, M [1 ]
机构
[1] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Aoba Ku, Sendai, Miyagi 9808575, Japan
关键词
angiogenesis; VEGF; PD-ECGF; lung cancer; microvessel density;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. In order to elucidate the roles of tumor angiogenesis in lung carcinogenesis, the expressions of several angiogenic factors in lung carcinoma tissues were examined. Materials and Methods. Tissue specimens from 112 cases of resected non-small cell lung cancel (NSCLC) were studied. The expressions of platelet-derived endothelial cell growth factor (PD-ECGF) and vascular endothelial growth factor (VEGF) were examined immunohistochemically. Microvessel density (MVD) was also evaluated. Results. VEGF-positive cases were observed more frequently in advanced stage lung cancers than in early cancers and VEGF-positive rumors had higher MVD than VEGF-negative tumors, while such differences were not observed for PD-ECGF. In squamous cell carcinoma, the patients with hgh-MVD tumor had significantly worse survival than those with low-MVD tumor. Conclusions. Our results suggest that VEGF plays an important role in angiogenesis of lung cancers, wile the contribution of PD-ECGF may be limited.
引用
收藏
页码:4305 / 4309
页数:5
相关论文
共 50 条
  • [31] Expression of neuroendocrine markers in non-small cell lung cancer - A biochemical, immunohistochemical and ultrastructural study
    Sorhaug, Sveinung
    Steinshamn, Sigurd
    Haaverstad, Rune
    Nordrum, Ivar S.
    Martinsen, Tom C.
    Waldum, Helge L.
    APMIS, 2007, 115 (02) : 152 - 163
  • [32] Editorial: Prognostic factors in non-small cell lung cancer
    Rahouma, Mohamed
    Baudo, Massimo
    Zhang, Jun
    Mutti, Luciano
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [33] Clinical factors and prognosis in non-small cell lung cancer
    Martins, SJ
    Pereira, JR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05): : 453 - 457
  • [34] Prognoztic factors in non-small cell lung cancer:: Review
    Yaren, Arzu
    Oeztop, Ilhan
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2007, 27 (01): : 72 - 78
  • [35] Prognostic factors in non-small cell lung cancer surgery
    Birim, Ö
    Kappetein, AP
    van Klaveren, R
    Bogers, AMC
    EJSO, 2006, 32 (01): : 12 - 23
  • [36] Prognostic factors for patients with non-small cell lung cancer
    Rosvold, E
    CURRENT PROBLEMS IN CANCER, 1996, 20 (04) : 272 - 278
  • [37] Peptides and growth factors in non-small cell lung cancer
    Moody, TW
    PEPTIDES, 1996, 17 (03) : 545 - 555
  • [38] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [39] Prognostic significance of immunohistochemical markers in non-small cell lung cancer.
    Renouf, D.
    Wood-Baker, R.
    Ionescu, D.
    Leung, S.
    Massoudi, H.
    Gilks, B.
    Laskin, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 416S - 416S
  • [40] Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis
    Wang, Feng
    Liu, Yanhong
    Chen, Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1595 - 1600